203 related articles for article (PubMed ID: 18370965)
1. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.
Simoni-Wastila L; Zuckerman IH; Shaffer T; Blanchette CM; Stuart B
Health Serv Res; 2008 Apr; 43(2):496-514. PubMed ID: 18370965
[TBL] [Abstract][Full Text] [Related]
2. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
Donohue JM; Frank RG
Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
[TBL] [Abstract][Full Text] [Related]
3. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
Simeone JC; Marcoux RM; Quilliam BJ
J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
[TBL] [Abstract][Full Text] [Related]
4. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions.
Yang HW; Simoni-Wastila L; Zuckerman IH; Stuart B
Psychiatr Serv; 2008 Apr; 59(4):384-91. PubMed ID: 18378837
[TBL] [Abstract][Full Text] [Related]
6. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
[TBL] [Abstract][Full Text] [Related]
7. Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes.
Stevenson DG; O'Malley AJ; Dusetzina SB; Mitchell SL; Zarowitz BJ; Chernew ME; Newhouse JP; Huskamp HA
J Am Geriatr Soc; 2014 Sep; 62(9):1666-74. PubMed ID: 25123044
[TBL] [Abstract][Full Text] [Related]
8. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
9. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
[TBL] [Abstract][Full Text] [Related]
10. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Coverage Restrictions on Antipsychotic Utilization Among Low-Income Medicare Part D Enrollees.
Roberto PN; Brandt N; Onukwugha E; Perfetto E; Powers C; Stuart B
Adm Policy Ment Health; 2017 Nov; 44(6):943-954. PubMed ID: 28660370
[TBL] [Abstract][Full Text] [Related]
12. Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.
Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey M; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Adimora AA
AIDS Care; 2019 Apr; 31(4):505-512. PubMed ID: 30189747
[TBL] [Abstract][Full Text] [Related]
13. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs.
Svarstad BL; Shireman TI; Sweeney JK
Psychiatr Serv; 2001 Jun; 52(6):805-11. PubMed ID: 11376229
[TBL] [Abstract][Full Text] [Related]
14. Policy implications of Medicare Part D for adults with mental illness: a qualitative exploration.
Hensley MA
Soc Work Public Health; 2012; 27(3):238-49. PubMed ID: 22486429
[TBL] [Abstract][Full Text] [Related]
15. Economic grand rounds: did Medicare Part D improve access to medications?
Domino ME; Farley JF
Psychiatr Serv; 2010 Feb; 61(2):118-20. PubMed ID: 20123814
[TBL] [Abstract][Full Text] [Related]
16. Differential Effects by Mental Health Status of Filling the Medicare Part D Coverage Gap.
Liu J; Zhang Y; Kaplan CM
Med Care; 2022 Feb; 60(2):133-139. PubMed ID: 35030562
[TBL] [Abstract][Full Text] [Related]
17. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
18. Use of and spending on supportive care medications among Medicare beneficiaries with cancer.
Zuckerman IH; Davidoff AJ; Erten MZ; Stuart B; Shaffer T; Dougherty JS; Yong C
Support Care Cancer; 2014 Aug; 22(8):2185-95. PubMed ID: 24659243
[TBL] [Abstract][Full Text] [Related]
19. Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk.
McAlpine DD; Mechanic D
Health Serv Res; 2000 Apr; 35(1 Pt 2):277-92. PubMed ID: 10778815
[TBL] [Abstract][Full Text] [Related]
20. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
McWilliams JM; Zaslavsky AM; Huskamp HA
JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
